6-month MA price graph of Asiapharm
Applying simple technical analysis,for a 10 day - 20 day moving average comparison, there is a upward trend for Asiapharm. Applying simple fundamentals: rising price, good trading volume, good company fundamentals, good corporate news, strengthening of Chinese yuan, potential growth in pharmeceutical sector.....all points toward a buy for this stock! DBS Vickers recommends a BUY for the stock with price target of S$1.00.
Other stocks heavily invested in China which will be likely to benefit from the strengthening of yuan include Keppeland, Capitaliand, Cap-China REIT etc.
Current Stock Watch: Lifebrandz, Capitaland, Asiapharm, Sapphire
No comments:
Post a Comment